April 24, 2026
The investment will help researchers develop innovative research projects aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.
April 17, 2026
UNC research advises physicians carefully evaluate how much muscle composition patients lose while taking popular drugs for weight loss.
April 10, 2026
The study shows that drug citarinostat can awaken hidden HIV, advancing efforts towards a potential cure for the complex virus.
April 1, 2026
The prestigious honor recognizes biochemist Jean Cook, PhD, and her work on cancer development and the human cell cycle, a biological process crucial for development, healing, and continued maintenance of the body.
March 23, 2026
With a medical degree and a master’s in business administration, Scott Giberson aims to transform healthcare systems while making a meaningful difference for children and their families.
March 5, 2026
In a new paper, researchers propose treating health data as essential national infrastructure, balancing patient empowerment, privacy, innovation, and public good.
February 26, 2026
A geneticist at the UNC School of Medicine has coordinated the development of Mondo, the world’s first standardized rare disease coding tool. Mondo is designed to streamline the diagnosis and treatment planning for millions of patients with rare diseases internationally.
February 19, 2026
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.
February 16, 2026
The tool is a one-stop resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.
February 2, 2026
Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with chronic bronchitis, chronic obstructive pulmonary disease (COPD), or asthma before symptoms start.
January 28, 2026
The clinical trial, led by James Howard Jr., MD., shows that a single course of six once-weekly infusions of Descartes-08 resulted in sustained clinically meaningful responses among patients with generalized myasthenia gravis.
January 27, 2026
Microbiologists at the UNC School of Medicine point to a specific protein that interferes with common antibiotics and their abilities to completely kill off bacteria.